Contract 75H71023F80233
Roche Diabetes Care Inc · Department Of Health And Human Services · April 10, 2023
Roche Diabetes Care Inc was awarded a federal contract by Department Of Health And Human Services (Indian Health Service) on April 10, 2023 for $100,000 of work in in-vitro diagnostic substance manufacturing. Performance is in Gallup, NM. This is a task or delivery order issued under parent IDIQ V797D50597. It uses firm fixed-price contract pricing.
Contract details
- PIID
- 75H71023F80233
- Parent IDIQ
- V797D50597
- Award type
- Delivery Order
- Pricing
- Firm Fixed Price
- Competition
- Full And Open Competition
- NAICS
- 325413 · In-Vitro Diagnostic Substance Manufacturing
- Product / service
- Medical And Surgical Instruments, Equipment, And Supplies
- Place of performance
- Gallup, NM
- First action
- April 10, 2023
Description
OUT-PATIENT DIABETES SUPPLIES
Modification timeline
-
April 10, 2023Base award$100.0K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Roche Diagnostics Corporation | Department Of Health And Human Services | April 1, 2026 | $313.4K |
| Roche Diagnostics Corporation | Department Of Health And Human Services | April 1, 2026 | $75.2K |
| Sysmex America, Inc | Department Of Health And Human Services | March 31, 2026 | $49.2K |
| Becton, Dickinson And Company | Department Of Health And Human Services | March 31, 2026 | $5.7K |
| Biomerieux Inc | Department Of Health And Human Services | March 31, 2026 | $0 |
| Beckman Coulter, Inc. | Department Of Health And Human Services | March 30, 2026 | $80.2K |
Top contractors in NAICS 325413
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Abbott Rapid Dx North America Llc | 651 | $3.51B |
| 2 | Ihealth Labs Inc. | 4 | $2.13B |
| 3 | Roche Diagnostics Corporation | 5,604 | $959.60M |
| 4 | Siemens Healthcare Diagnostics Inc. | 818 | $641.45M |
| 5 | Cepheid | 3,693 | $639.45M |
| 6 | Remel Inc. | 4,525 | $464.47M |
| 7 | Access Bio, Inc. | 5 | $340.72M |
| 8 | Ortho-Clinical Diagnostics, Inc | 1,964 | $227.77M |
| 9 | Quidel Corp | 96 | $194.78M |
| 10 | Ortho-Clinical Diagnostics Inc | 2,494 | $183.46M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75H71023F80233?
Contract 75H71023F80233 is a federal contract awarded to Roche Diabetes Care Inc by Department Of Health And Human Services on April 10, 2023 for $100,000 of work classified under IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING. It has been modified 0 times since the base award.
Who won contract 75H71023F80233?
Roche Diabetes Care Inc won contract 75H71023F80233 from Department Of Health And Human Services.
How much is contract 75H71023F80233 worth?
Contract 75H71023F80233 has obligated $100,000 to date.